Tweenvest Stocks

Avidity Biosciences, Inc. (NasdaqGM: RNAM)

Health Care · Biotechnology · US

$—

— today · — 1Y

Avidity Biosciences, Inc. (NasdaqGM: RNAM) operates in the Biotechnology industry within the Health Care sector.

trading between 46.29 and 73.06.

Tweenvest scores Avidity Biosciences, Inc. across four factors: quality 39/100, value 56/100, growth 100/100. Its strongest factor is growth.

RNAM price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
$18.75M
P/E
—
EPS
-4.97
Dividend yield
—
Beta (5Y)
—
52-week high
$73.06
52-week low
$46.29
Avg volume (3M)
—
Shares outstanding
—
Employees
511
Next earnings
—

About Avidity Biosciences, Inc.

Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases. The company was established on November 13, 2012, by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick, and its main office is located in San Diego, California.

ISIN
US05370A1088
Founded
2012
Listed since
Jun 12, 2020
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$——
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.00—
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$——
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.00—
Calithera Biosciences, Inc.OTCPK: CALA$5.00$0.00-99.00%
Biocept, Inc.OTCPK: BIOC.Q$3.00$0.00-99.50%
Yield10 Bioscience, Inc.OTCPK: YTEN.Q$1.00$——
LadRx CorporationOTCPK: LADX$0.00$0.00-99.50%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.